LB Pharmaceuticals Inc (LBRX) PT Raised to $54 at BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts LBRX Hot Sheet
Price: $40.85 --0%
Rating Summary:
11 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
11 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
BMO Capital analyst Malcolm Hoffman raised the price target on LB Pharmaceuticals Inc (NASDAQ: LBRX) to $54.00 (from $46.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Arm Holdings (ARM) PT Lowered to $250 at TD Cowen
- IPG Photonics (IPGP) PT Lowered to $92 at Bernstein SocGen Group
- Arm Holdings (ARM) PT Lowered to $300 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
